We are often contacted by businesses when they are facing a licensing hearing for their variation application, only to find that the application needs to be effectively re-started, adding time, cost ...

Small administrative changes and designated premises supervisor variations have their own straightforward processes. Any other changes, for example, to the hours, activities, conditions or plans ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

I, Shoncee Bani-Sadr, Hereby give notice that I have applied to Southampton City Council for variation of a premises licence under part 3 of the Licensing Act 2003, as follows: Postal address of ...

Daiichi Sankyo announced that the European Medicines Agency (EMA) has validated the Type II Variation application for Enhertu (trastuzumab deruxtecan) as a monotherapy for the treatment of adult ...

Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1) ...

TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) today announced that the European Medicines Agency (EMA) has validated the Type II Variation application for trastuzumab deruxtecan as ...

TOKYO, Japan & MUNICH, Germany--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has validated the Type II ...